SAN CARLOS, Calif.--(BUSINESS WIRE)--April 26, 2006--NuGEN Technologies Inc., a privately held company that develops and commercializes the new standard in RNA amplification and labeling systems, today announced the release of an application note detailing results of a U.S.-government lab study in which NuGEN’s Ovation Biotin system provided increased speed to results and higher specificity of hybridization on GeneChip® probe arrays starting with as little as 50 nanograms of human whole blood total RNA. The study demonstrated the Ovation system yielded a significantly higher percentage of genes called present. Since the Ovation system generates cDNA rather than cRNA, hybridization to the DNA content on the Affymetrix GeneChip array results in greater specificity.
